Febrile non-haemolytic |
· Donor blood storage -> cytokine accumulation (IL-1, IL-6, TNF-α) · Fever, malaise, dyspnoea · Not harmful |
Febrile haemolytic |
· Due to incompatible transfusion · RBC > platelets > FFP · (Normal) prior alloimmunisation due to molecular mimicry by gut flora · Donor antigen vs recipient antibody · ABO IgM-> intravascular haemolysis (DIC, renal failure, death) · RhD IgG-> extravascular haemolysis (haemolytic anaemia) |
Anaphylaxis |
· Type 1 hypersensitivity · FFP and platelets > RBC · Donor protein vs recipient IgE · Especially IgA vs IgA-deficient host · Mast cell degranulation -> vasodilation, bronchospasm, angioedema |
TRALI |
· Transfusion-related acute lung injury · FFP and platelets > RBC · ? Donor antibody vs recipient lung antigen · ? Illness-related priming of neutrophils and endothelium · Non-cardiogenic pulmonary oedema · Major cause of mortality · FFP and platelets > others · Onset during transfusion or < 6 hours |
Alloimmunisation |
· First exposure to antigen during transfusion or childbirth · Alloantibodies produced · Second exposure results in antibody-mediated destruction Delayed haemolytic reaction: · Especially if recurrent transfusion · Antibodies: Kell, Kidd, Duffy · Diminishing antibody titre -> re-exposure -> anamnestic response · Extravascular haemolysis -> haemolytic anaemia Haemolytic disease of the newborn: · RhD+ foetus vs RhD- mother; or Kell(+) foetus vs Kell(-) mother · IgG crosses placenta -> severe haemolysis · Prevented by anti-D at 28/40 and 34/40 in RhD- women Post-transfusion purpura: · Donor platelet vs recipient alloantibodies · Consumption of both donor platelets and bystanders |
Immunomodulation |
· Mechanism unclear - ? donor WBC or mediators · ↑Post-op infection, ↑cancer recurrence · Rationale for cell salvage use in major cancer surgery |
Graft vs host |
· Donor WBC multiplies in immunocompromised host -> tissue damage · Affects skin (rash), marrow (suppression), liver (↑LFT), GIT (diarrhoea) · Rare, fatal, untreatable · Prevented by gamma irradiation of blood product |
Feedback welcome at ketaminenightmares@gmail.com